Global Florfenicol Market Growth 2023-2029
Florfenicol is a monofluorinated derivative of thiamphenicol. Florfenicol is a chloramphenicol broad-spectrum antibiotic that can effectively inhibit bacteria. Its antibacterial activity is stronger than that of chloramphenicol and thiamphenicol. Florfenicol overcomes the problems that chloramphenicol is prone to drug resistance and aplastic anemia, and has the characteristics of wide antibacterial spectrum, good oral absorption, wide distribution in the body, high bioavailability, and safe application.
LPI (LP Information)' newest research report, the “Florfenicol Industry Forecast” looks at past sales and reviews total world Florfenicol sales in 2022, providing a comprehensive analysis by region and market sector of projected Florfenicol sales for 2023 through 2029. With Florfenicol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Florfenicol industry.
This Insight Report provides a comprehensive analysis of the global Florfenicol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Florfenicol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Florfenicol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Florfenicol and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Florfenicol.
The global Florfenicol market size is projected to grow from US$ 375.1 million in 2022 to US$ 530.7 million in 2029; it is expected to grow at a CAGR of 530.7 from 2023 to 2029.
The industry's leading producers are Merck Animal Health, Hisoar Pharmaceutical and Lianhuan Pharmaceutical, with revenues of 16.19%, 13.03% and 12.25%, respectively, in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Florfenicol market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity ≥ 98%
Purity ≥ 99.5%
Segmentation by application
Livestock
Poultry
Aquaculture
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck Animal Health
Hisoar Pharmaceutical
Lianhuan Pharmaceutical
Hansyn Pharma
Zhejiang Kangmu Pharmaceutical
CAHIC
ShanDong Guobang Pharmaceutical
Longxiang Pharmaceutical
Masteam Bio-tech
Hankuo
Runkang Pharmaceutical
Jiangxi Dongxu
Interchemie
Temad
Tecoland
Key Questions Addressed in this Report
What is the 10-year outlook for the global Florfenicol market?
What factors are driving Florfenicol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Florfenicol market opportunities vary by end market size?
How does Florfenicol break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook